Elevated CD93 is associated with immune cell infiltration in tumor tissues, low immunotherapy responses in cancer patients, tumor angiogenesis, poor prognosis, high tumor nodes, and metastasis (TNM) stages in several cancer types [53]. Here, CD93 is linked to neoplasm.